Merck & Co. Inc. (NYSE:MRK) will not exercise its option for Evaxion A/S (NASDAQ:EVAX) Gonorrhea vaccine candidate EVX-B2. Gonorrhoea is a common, sexually transmitted infection caused by Neisseria gonorrhoeae. Consequently, Evaxion retains global rights to EVX-B2 and will look for…
While the gold market tends to dominate the precious metals discourse, it's silver that is currently consuming investors' attention at this hour. In early October, silver reached a historical threshold, climbing to $50 per ounce and smashing the previous record…
Although the broader equities market can occasionally vacillate between order and outright chaos, small-capitalization enterprises tend to amplify the extreme ends of behavioral distribution. By their nature, businesses that are less financially resourced must operate with tighter margins for error.…
Shares of Nike Inc (NYSE:NKE) continued to tank in early trading on Friday, even after the company Thursday reported upbeat fiscal second-quarter results. Here are the key analyst takeaways: Needham analyst Tom Nikic reaffirmed a Buy rating, while cutting the…
Accenture Plc (NYSE:ACN) executives on the first-quarter earnings call said client demand has increased steadily over the past nine quarters, with roughly 100 incremental clients initiating AI projects during that period. Management cautioned, however, that AI deployments remain in early…
U.S. stocks were higher, with the Dow Jones index gaining more than 250 points on Friday. Shares of Carnival PLC (NYSE:CUK) rose sharply during Thursday's session after the company announced better-than-expected fourth-quarter adjusted EPS results and issuedFY26 adjusted EPS guidance…
Carnival Corporation & plc (NYSE:CCL) (NYSE:CUK) delivered a decisive earnings beat and reinstated its dividend after posting record fourth-quarter profit and cash flow. Carnival reported fourth-quarter net income of $422 million, or 31 cents per share, up nearly 40% from…
Cassava Sciences Inc. (NASDAQ:SAVA) received a formal letter from the U.S. Food and Drug Administration (FDA) related to the company’s trial for simufilam Following previously reported communications with the FDA regarding Cassava’s investigational new drug application and proposed proof-of-concept clinical…
CarMax Inc. (NYSE:KMX) reported its fiscal third-quarter results on Thursday, broadly in line with its guidance range. Here are the key analyst takeaways: Stephens analyst Jeff Lick maintained an Equal-Weight rating, while reducing the price target from $39 to $36. RBC Capital Markets…
While Birkenstock Holding PLC (NYSE:BIRK) reported better-than-expected fourth-quarter results, this was overshadowed by the ongoing forex and tariff pressures, according to Guggenheim Securities. • Birkenstock Holding shares are under pressure. What’s pulling BIRK shares down? The Birkenstock Holding Analyst: Analyst…